DiNAQOR has developed a proprietary technology platform and manufacturing capabilities designed to overcome the challenges and limitations of early-stage gene therapy development.
Products, services, technology
Our platform consists of three core components: our human-based engineered heart tissue (EHT) technology; our LRP System which enables organ-specific delivery of gene therapies; and DiNAMIQS, our Contract Development and Manufacturing Organization based in Schlieren-Zürich.
- http://www.dinaqor.com
- +41 55 417 40 50
- info@dinaqor.com
- Johannes Holzmeister
